Results 1 to 2 of about 3 (2)
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. [PDF]
Pharmacoecon Open, 2019 Eribulin is a recommended treatment option for locally advanced or metastatic breast cancer (LABC/MBC) in adults whose disease has progressed after at least two chemotherapy regimens.
Fleeman N +8 more
europepmc +2 more sources